Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model

<div>Representative histological and electron microscopic images of Promus PREMIER™ and Synergy™ on the 14<sup>th</sup> day after implantation. Promus PREMIER™ (a) and Synergy™ (b) were completely coved with the neointimal layer. The struts of Promus PREMIER™ showed moderate deposition of fibrin (black allow head) and aggregation of inflammatory cells (black allow). Smooth muscle cells were present in Synergy™. As observed through scanning electron microscopy, Promus PREMIER™ (c) and Synergy™ (d) were completely covered with the neointimal layer with smoother surface than that observed on the 2<sup>nd</sup> day. The scale bars are 100 <i>µ</i>m (histological images) and 30 <i>µ</i>m (electron microscopic images).</div>

Journal of Interventional Cardiology

fig2

Figure 2

Figure 2: Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model 

Figure 2 | Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model 